Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria.
Thirteen patients with phenylketonuria, detected by neonatal screening and started on diet within 16 days of age, were investigated between 10 and 18 years of age by magnetic resonance imaging (MRI) of the brain. Biochemical control was assessed from: (1) the life time blood phenylalanine (Phe) control (as determined from (a) the mean yearly exposure to Phe; (b) the accumulated time for each patient that Phe was < 120 mumol/l; (c) > 400 mumol/l; (d) > 800 mumol/l; and (e) > 1200 mumol/l); and (2) the blood Phe control over the 5 years prior to imaging (assessed for each patient by the mean yearly Phe exposure over that period). In all patients the phenylalanine hydroxylase gene locus was studied using restriction fragment length polymorphism haplotypes and mutant genes were screened for a variety of specific mutations which have been reported in other European populations or in populations of north European descent. Two patients had significant abnormalities of cerebral white matter. Although both showed poor biochemical control this did not reach statistical significance when compared to those with normal imaging. DNA haplotype patterns could be assigned to 11 patients and mutant genes were identified in 12. One patient with abnormal imaging and 4 patients without abnormalities had mutations on both chromosomes identified. In these 5 patients there was significant correlation between their genotype and biochemical control. Mutations resulting in residual in vitro enzyme activity were associated with normal imaging.
Walter
J H
JH
Department of Child Health, Royal Hospital for Sick Children, Bristol, United Kingdom.
Tyfield
L A
LA
Holton
J B
JB
Johnson
C
C
D000293:Adolescent; D001921:Brain / Q000473:pathology; D002648:Child; D004247:DNA / Q000032:analysis; D006239:Haplotypes; D006801:Humans; D008279:Magnetic Resonance Imaging; D009154:Mutation; D010649:Phenylalanine / Q000097:blood; D010661:Phenylketonurias / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D012150:Polymorphism, Restriction Fragment Length
D010649:Phenylalanine; D004247:DNA